Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

NASDAQ:ACLS - Nasdaq - US0545402085 - Common Stock - Currency: USD

71.99  +2.3 (+3.3%)

After market: 71.99 0 (0%)

Fundamental Rating

7

Overall ACLS gets a fundamental rating of 7 out of 10. We evaluated ACLS against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS gets an excellent profitability rating and is at the same time showing great financial health properties. ACLS is not valued too expensively and it also shows a decent growth rate. This makes ACLS very considerable for quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year ACLS was profitable.
ACLS had a positive operating cash flow in the past year.
Each year in the past 5 years ACLS has been profitable.
ACLS had a positive operating cash flow in each of the past 5 years.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

ACLS has a Return On Assets of 13.35%. This is amongst the best in the industry. ACLS outperforms 83.64% of its industry peers.
The Return On Equity of ACLS (17.43%) is better than 80.91% of its industry peers.
The Return On Invested Capital of ACLS (14.18%) is better than 86.36% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACLS is significantly above the industry average of 10.58%.
The 3 year average ROIC (21.38%) for ACLS is well above the current ROIC(14.18%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.35%
ROE 17.43%
ROIC 14.18%
ROA(3y)17.38%
ROA(5y)14.65%
ROE(3y)25.24%
ROE(5y)20.88%
ROIC(3y)21.38%
ROIC(5y)18.43%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS has a better Profit Margin (18.68%) than 79.09% of its industry peers.
ACLS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 19.21%, ACLS is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
ACLS's Operating Margin has improved in the last couple of years.
The Gross Margin of ACLS (44.61%) is comparable to the rest of the industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.21%
PM (TTM) 18.68%
GM 44.61%
OM growth 3Y2.56%
OM growth 5Y24.06%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACLS is creating value.
ACLS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ACLS has been reduced compared to 5 years ago.
The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 6.78 indicates that ACLS is not in any danger for bankruptcy at the moment.
ACLS has a better Altman-Z score (6.78) than 69.09% of its industry peers.
ACLS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.35, ACLS belongs to the top of the industry, outperforming 80.91% of the companies in the same industry.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
ACLS has a better Debt to Equity ratio (0.04) than 60.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 6.78
ROIC/WACC1.39
WACC10.18%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.57 indicates that ACLS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.57, ACLS belongs to the best of the industry, outperforming 82.73% of the companies in the same industry.
A Quick Ratio of 4.09 indicates that ACLS has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.09, ACLS is doing good in the industry, outperforming 74.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.57
Quick Ratio 4.09
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -25.76% in the last year.
The Earnings Per Share has been growing by 64.54% on average over the past years. This is a very strong growth
Looking at the last year, ACLS shows a very negative growth in Revenue. The Revenue has decreased by -15.14% in the last year.
Measured over the past years, ACLS shows a very strong growth in Revenue. The Revenue has been growing by 24.30% on average per year.
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%

3.2 Future

The Earnings Per Share is expected to grow by 24.02% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACLS will show a very negative growth in Revenue. The Revenue will decrease by -10.41% on average per year.
EPS Next Y-45.38%
EPS Next 2Y-22.39%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue Next Year-25.43%
Revenue Next 2Y-10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

ACLS is valuated correctly with a Price/Earnings ratio of 12.81.
Based on the Price/Earnings ratio, ACLS is valued cheaply inside the industry as 93.64% of the companies are valued more expensively.
ACLS is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.43 indicates a rather expensive valuation of ACLS.
Based on the Price/Forward Earnings ratio, ACLS is valued a bit cheaper than the industry average as 70.91% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, ACLS is valued at the same level.
Industry RankSector Rank
PE 12.81
Fwd PE 19.43
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ACLS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACLS is cheaper than 94.55% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 85.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.7
EV/EBITDA 6.44
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACLS's earnings are expected to grow with 24.02% in the coming years.
PEG (NY)N/A
PEG (5Y)0.2
EPS Next 2Y-22.39%
EPS Next 3Y24.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (7/1/2025, 6:34:10 PM)

After market: 71.99 0 (0%)

71.99

+2.3 (+3.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)07-29 2025-07-29/amc
Inst Owners104.06%
Inst Owner Change1.35%
Ins Owners0.95%
Ins Owner Change8.46%
Market Cap2.31B
Analysts72.86
Price Target88.86 (23.43%)
Short Float %16.77%
Short Ratio8.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.39%
Min EPS beat(2)20.83%
Max EPS beat(2)163.95%
EPS beat(4)4
Avg EPS beat(4)49.55%
Min EPS beat(4)2.16%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)32.98%
EPS beat(12)12
Avg EPS beat(12)27.59%
EPS beat(16)16
Avg EPS beat(16)26.09%
Revenue beat(2)2
Avg Revenue beat(2)1.57%
Min Revenue beat(2)1.02%
Max Revenue beat(2)2.12%
Revenue beat(4)3
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.12%
Revenue beat(8)7
Avg Revenue beat(8)1.66%
Revenue beat(12)11
Avg Revenue beat(12)1.99%
Revenue beat(16)15
Avg Revenue beat(16)2.52%
PT rev (1m)4.06%
PT rev (3m)-5.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)47.47%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)41.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.78%
Valuation
Industry RankSector Rank
PE 12.81
Fwd PE 19.43
P/S 2.41
P/FCF 18.7
P/OCF 16.64
P/B 2.25
P/tB 2.25
EV/EBITDA 6.44
EPS(TTM)5.62
EY7.81%
EPS(NY)3.7
Fwd EY5.15%
FCF(TTM)3.85
FCFY5.35%
OCF(TTM)4.33
OCFY6.01%
SpS29.82
BVpS32
TBVpS32
PEG (NY)N/A
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 13.35%
ROE 17.43%
ROCE 16.13%
ROIC 14.18%
ROICexc 29.22%
ROICexgc 29.22%
OM 19.21%
PM (TTM) 18.68%
GM 44.61%
FCFM 12.91%
ROA(3y)17.38%
ROA(5y)14.65%
ROE(3y)25.24%
ROE(5y)20.88%
ROIC(3y)21.38%
ROIC(5y)18.43%
ROICexc(3y)45.43%
ROICexc(5y)37.56%
ROICexgc(3y)45.43%
ROICexgc(5y)37.56%
ROCE(3y)24.31%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.57%
ROICexcg growth 5Y39.04%
ROICexc growth 3Y-3.57%
ROICexc growth 5Y39.04%
OM growth 3Y2.56%
OM growth 5Y24.06%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.21
Cap/Depr 92.8%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 69.32%
Profit Quality 69.08%
Current Ratio 5.57
Quick Ratio 4.09
Altman-Z 6.78
F-Score6
WACC10.18%
ROIC/WACC1.39
Cap/Depr(3y)109.59%
Cap/Depr(5y)96.82%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.12%
Profit Quality(5y)99.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
EPS Next Y-45.38%
EPS Next 2Y-22.39%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%
Revenue Next Year-25.43%
Revenue Next 2Y-10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.22%
EBIT growth 3Y18.35%
EBIT growth 5Y54.2%
EBIT Next Year-45.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.94%
FCF growth 3Y-3.04%
FCF growth 5YN/A
OCF growth 1Y-38.06%
OCF growth 3Y-2.08%
OCF growth 5YN/A